The prostaglandin receptor EP2 determines prognosis in EP3-negative and galectin-3-high cervical cancer cases

Recently our study identified EP3 receptor and galectin-3 as prognosticators of cervical cancer. The aim of the present study was the analysis of EP2 as a novel marker and its association to EP3, galectin-3, clinical pathological parameters and the overall survival rate of cervical cancer patients....

Descripción completa

Detalles Bibliográficos
Autores principales: Dietlmeier, Sebastian, Ye, Yao, Kuhn, Christina, Vattai, Aurelia, Vilsmaier, Theresa, Schröder, Lennard, Kost, Bernd P., Gallwas, Julia, Jeschke, Udo, Mahner, Sven, Heidegger, Helene Hildegard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6981231/
https://www.ncbi.nlm.nih.gov/pubmed/31980713
http://dx.doi.org/10.1038/s41598-020-58095-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6981231/
https://www.ncbi.nlm.nih.gov/pubmed/31980713
http://dx.doi.org/10.1038/s41598-020-58095-3

Ejemplares similares